Transcriptional profiling of disease-induced host responses in bovine tuberculosis and the identification of potential diagnostic biomarkers

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Aranday Cortes, Elihu ^a   Hogarth, Philip J ^a   Kaveh, Daryan A ^a   Whelan, Adam O ^a   Villarreal Ramos, Bernardo ^a   Lalvani, Ajit ^b   Vordermeier, H Martin ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; RNA; TRANSCRIPTOME; CXCL10 PROTEIN, MOUSE; CXCL9 CHEMOKINE; CXCL9 PROTEIN, MOUSE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANZYME; INTERLEUKIN 22; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BOVINE TUBERCULOSIS; CCR6 GENE; CHEMOKINE CX MOTIF LIGAND 10 GENE; CHEMOKINE CX MOTIF LIGAND 9 GENE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EXPERIMENTAL MOUSE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GRANZYME A GENE; GRANZYME B GENE; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOSTIMULATION; IN VITRO STUDY; INTERLEUKIN 22 GENE; LUNG ALVEOLUS CELL; MICROARRAY ANALYSIS; MOLECULAR PROBE; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SPLEEN CELL; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; CATTLE; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUNG; MICROBIOLOGY; PATHOLOGY; SPLEEN;

ANIMALIA; BOS; BOVINAE; MURINAE; MUS; MYCOBACTERIUM BOVIS;

ANIMALS; BIOLOGICAL MARKERS; CATTLE; CHEMOKINE CXCL10; CHEMOKINE CXCL9; GENE EXPRESSION PROFILING; GRANZYMES; HOST-PATHOGEN INTERACTIONS; INTERLEUKINS; LUNG; MICE; SPLEEN; TUBERCULOSIS, BOVINE; UP-REGULATION;

EID: 84857127214     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030626     Document Type: Article

References (52)

1. Thoen C, Lobue P, de Kantor I, (2006) The importance of Mycobacterium bovis as a zoonosis. Vet Microbiol 112: 339-345.
2. Schiller I, Oesch B, Vordermeier HM, Palmer MV, Harris BN, et al. (2010) Bovine tuberculosis: a review of current and emerging diagnostic techniques in view of their relevance for disease control and eradication. Transbound Emerg Dis 57: 205-220.
3. Gormley E, Doyle MB, Fitzsimons T, McGill K, Collins JD, (2006) Diagnosis of Mycobacterium bovis infection in cattle by use of the gamma-interferon (Bovigam) assay. Vet Microbiol 112: 171-179.
4. Wood PR, Jones SL, (2001) BOVIGAM: an in vitro cellular diagnostic test for bovine tuberculosis. Tuberculosis (Edinb) 81: 147-155.
5. Lalvani A, Millington KA, (2008) T Cells and Tuberculosis: Beyond Interferon-gamma. J Infect Dis 197: 941-943.
6. Jones GJ, Pirson C, Hewinson RG, Vordermeier HM, (2010) Simultaneous measurement of antigen-stimulated interleukin-1 beta and gamma interferon production enhances test sensitivity for the detection of Mycobacterium bovis infection in cattle. Clin Vaccine Immunol 17: 1946-1951.
7. Hogarth PJ, Logan KE, Vordermeier HM, Singh M, Hewinson RG, et al. (2005) Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c-a member of the esat-6 gene family. Vaccine 23: 2557-2564.
8. Chegou NN, Black GF, Kidd M, van Helden PD, Walzl G, (2009) Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med 9: 21.
9. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, et al. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178: 2249-2254.
10. Vordermeier HM, Villarreal-Ramos B, Cockle PJ, McAulay M, Rhodes SG, et al. (2009) Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect Immun 77: 3364-3373.
11. Aranday Cortes E, Kaveh D, Nunez-Garcia J, Hogarth PJ, Vordermeier HM, (2010) Mycobacterium bovis-BCG vaccination induces specific pulmonary transcriptome biosignatures in mice. PLoS ONE 5: e11319.
12. Vordermeier HM, Cockle PC, Whelan A, Rhodes S, Palmer N, et al. (1999) Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle. Clin Diagn Lab Immunol 6: 675-682.
13. Blanco FC, Bianco MV, Meikle V, Garbaccio S, Vagnoni L, et al. (2011) Increased IL-17 expression is associated with pathology in a bovine model of tuberculosis. Tuberculosis (Edinb) 91: 57-63.
14. Vordermeier HM, Chambers MA, Cockle PJ, Whelan AO, Simmons J, et al. (2002) Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 70: 3026-3032.
15. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A, (2011) Immunological biomarkers of tuberculosis. Nat Rev Immunol 11: 343-354.
16. Zarate-Blades CR, Silva CL, Passos GA, (2011) The impact of transcriptomics on the fight against tuberculosis: focus on biomarkers, BCG vaccination, and immunotherapy. Clin Dev Immunol 2011: 192630.
17. Waters WR, Palmer MV, Thacker TC, Davis WC, Sreevatsan S, et al. (2011) Tuberculosis immunity: opportunities from studies with cattle. Clin Dev Immunol 2011: 768542.
18. Kaveh DA, Bachy VS, Hewinson RG, Hogarth PJ, (2011) Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge. PLoS ONE 6: e21566.
19. Sonnenberg GF, Fouser LA, Artis D, (2011) Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 12: 383-390.
20. Wilson MS, Feng CG, Barber DL, Yarovinsky F, Cheever AW, et al. (2010) Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J Immunol 184: 4378-4390.
21. Yao S, Huang D, Chen CY, Halliday L, Zeng G, et al. (2010) Differentiation, distribution and gammadelta T cell-driven regulation of IL-22-producing T cells in tuberculosis. PLoS Pathog 6: e1000789.
22. Dhiman R, Indramohan M, Barnes PF, Nayak RC, Paidipally P, et al. (2009) IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. J Immunol 183: 6639-6645.
23. Zeng G, Chen CY, Huang D, Yao S, Wang RC, et al. (2011) Membrane-bound IL-22 after de novo production in tuberculosis and anti-Mycobacterium tuberculosis effector function of IL-22+ CD4+ T cells. J Immunol 187: 190-199.
24. Scriba TJ, Kalsdorf B, Abrahams DA, Isaacs F, Hofmeister J, et al. (2008) Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 180: 1962-1970.
25. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, et al. (2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8: 369-377.
26. Khader SA, Cooper AM, (2008) IL-23 and IL-17 in tuberculosis. Cytokine 41: 79-83.
27. Wozniak TM, Saunders BM, Ryan AA, Britton WJ, (2010) Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect Immun 78: 4187-4194.
28. Nandi B, Behar SM, (2011) Regulation of neutrophils by interferon-{gamma} limits lung inflammation during tuberculosis infection. J Exp Med 208: 2251-2262.
29. Okamoto Yoshida Y, Umemura M, Yahagi A, O'Brien RL, Ikuta K, et al. (2010) Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J Immunol 184: 4414-4422.
30. Clark S, Page E, Ford T, Metcalf R, Pozniak A, et al. (2011) Reduced T(H)1/T(H)17 CD4 T-cell numbers are associated with impaired purified protein derivative-specific cytokine responses in patients with HIV-1 infection. J Allergy Clin Immunol 128: 838-846 e835.
31. Peng MY, Wang ZH, Yao CY, Jiang LN, Jin QL, et al. (2008) Interleukin 17-producing gamma delta T cells increased in patients with active pulmonary tuberculosis. Cell Mol Immunol 5: 203-208.
32. Anthony DA, Andrews DM, Watt SV, Trapani JA, Smyth MJ, (2010) Functional dissection of the granzyme family: cell death and inflammation. Immunol Rev 235: 73-92.
33. Lieberman J, (2010) Granzyme A activates another way to die. Immunol Rev 235: 93-104.
34. Canaday DH, Wilkinson RJ, Li Q, Harding CV, Silver RF, et al. (2001) CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol 167: 2734-2742.
35. Gallegos AM, van Heijst JW, Samstein M, Su X, Pamer EG, et al. (2011) A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo. PLoS Pathog 7: e1002052.
36. Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, et al. (2009) T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31: 787-798.
37. Hamada H, Garcia-Hernandez Mde L, Reome JB, Misra SK, Strutt TM, et al. (2009) Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol 182: 3469-3481.
38. Lockhart E, Green AM, Flynn JL, (2006) IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 177: 4662-4669.
39. O'Brien RL, Roark CL, Born WK, (2009) IL-17-producing gammadelta T cells. Eur J Immunol 39: 662-666.
40. Roark CL, Simonian PL, Fontenot AP, Born WK, O'Brien RL, (2008) gammadelta T cells: an important source of IL-17. Curr Opin Immunol 20: 353-357.
41. Witte E, Witte K, Warszawska K, Sabat R, Wolk K, (2010) Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev 21: 365-379.
42. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F, (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10: 857-863.
43. Sallusto F, Lanzavecchia A, (2009) Human Th17 cells in infection and autoimmunity. Microbes Infect 11: 620-624.
44. Vesosky B, Rottinghaus EK, Stromberg P, Turner J, Beamer G, (2010) CCL5 participates in early protection against Mycobacterium tuberculosis. J Leukoc Biol 87: 1153-1165.
45. Qiu L, Huang D, Chen CY, Wang R, Shen L, et al. (2008) Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. J Infect Dis 198: 1514-1519.
46. Whittaker E, Gordon A, Kampmann B, (2008) Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PLoS ONE 3: e3901.
47. Ruhwald M, Petersen J, Kofoed K, Nakaoka H, Cuevas LE, et al. (2008) Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS ONE 3: e2858.
48. Ruhwald M, Dominguez J, Latorre I, Losi M, Richeldi L, et al. (2011) A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb) 91: 260-267.
49. Kasprowicz VO, Mitchell JE, Chetty S, Govender P, Huang KH, et al. (2011) A molecular assay for sensitive detection of pathogen-specific T-cells. PLoS ONE 6: e20606.
50. Logan KE, Gavier-Widen D, Hewinson RG, Hogarth PJ, (2008) Development of a Mycobacterium bovis intranasal challenge model in mice. Tuberculosis (Edinb) 88: 437-443.
51. Vordermeier M, Ameni G, Glass EJ, (2011) Cytokine responses of Holstein and Sahiwal zebu derived monocytes after mycobacterial infection. Trop Anim Health Prod.
52. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.